Literature DB >> 21372138

Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles.

Jing L Guo1, Virginia M-Y Lee.   

Abstract

Neurofibrillary tangles (NFTs) in Alzheimer disease and related tauopathies are composed of insoluble hyperphosphorylated Tau protein, but the mechanisms underlying the conversion of highly soluble Tau into insoluble NFTs remain elusive. Here, we demonstrate that introduction of minute quantities of misfolded preformed Tau fibrils (Tau pffs) into Tau-expressing cells rapidly recruit large amounts of soluble Tau into filamentous inclusions resembling NFTs with unprecedented efficiency, suggesting a "seeding"-recruitment process as a highly plausible mechanism underlying NFT formation in vivo. Consistent with the emerging concept of prion-like transmissibility of disease-causing amyloidogenic proteins, we found that spontaneous uptake of Tau pffs into cells is likely mediated by endocytosis, suggesting a potential mechanism for the propagation of Tau lesions in tauopathy brains. Furthermore, sequestration of soluble Tau by pff-induced Tau aggregates attenuates microtubule overstabilization in Tau-expressing cells, supporting the hypothesis of a Tau loss-of-function toxicity in cells harboring NFTs. In summary, our study establishes a cellular system that robustly develops authentic NFT-like Tau aggregates, which provides mechanistic insights into NFT pathogenesis and a potential tool for identifying Tau-based therapeutics.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21372138      PMCID: PMC3083182          DOI: 10.1074/jbc.M110.209296

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

1.  Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein.

Authors:  J Lewis; E McGowan; J Rockwood; H Melrose; P Nacharaju; M Van Slegtenhorst; K Gwinn-Hardy; M Paul Murphy; M Baker; X Yu; K Duff; J Hardy; A Corral; W L Lin; S H Yen; D W Dickson; P Davies; M Hutton
Journal:  Nat Genet       Date:  2000-08       Impact factor: 38.330

2.  Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells.

Authors:  V Vogelsberg-Ragaglia; J Bruce; C Richter-Landsberg; B Zhang; M Hong; J Q Trojanowski; V M Lee
Journal:  Mol Biol Cell       Date:  2000-12       Impact factor: 4.138

3.  Selective deposition of mutant tau in the FTDP-17 brain affected by the P301L mutation.

Authors:  T Miyasaka; M Morishima-Kawashima; R Ravid; W Kamphorst; K Nagashima; Y Ihara
Journal:  J Neuropathol Exp Neurol       Date:  2001-09       Impact factor: 3.685

4.  Tau filament formation in transgenic mice expressing P301L tau.

Authors:  J Götz; F Chen; R Barmettler; R M Nitsch
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

5.  Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure.

Authors:  M von Bergen; S Barghorn; L Li; A Marx; J Biernat; E M Mandelkow; E Mandelkow
Journal:  J Biol Chem       Date:  2001-10-17       Impact factor: 5.157

6.  Anionic micelles and vesicles induce tau fibrillization in vitro.

Authors:  Carmen N Chirita; Mihaela Necula; Jeff Kuret
Journal:  J Biol Chem       Date:  2003-05-01       Impact factor: 5.157

7.  Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model.

Authors:  Y P Wang; J Biernat; M Pickhardt; E Mandelkow; E-M Mandelkow
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-29       Impact factor: 11.205

Review 8.  Tau-mediated neurodegeneration in Alzheimer's disease and related disorders.

Authors:  Carlo Ballatore; Virginia M-Y Lee; John Q Trojanowski
Journal:  Nat Rev Neurosci       Date:  2007-09       Impact factor: 34.870

9.  Fibrillogenic nuclei composed of P301L mutant tau induce elongation of P301L tau but not wild-type tau.

Authors:  Hirofumi Aoyagi; Masato Hasegawa; Akira Tamaoka
Journal:  J Biol Chem       Date:  2007-05-25       Impact factor: 5.157

10.  Aberrant tau phosphorylation by glycogen synthase kinase-3beta and JNK3 induces oligomeric tau fibrils in COS-7 cells.

Authors:  Shinji Sato; Yoshitaka Tatebayashi; Takumi Akagi; De-Hua Chui; Miyuki Murayama; Tomohiro Miyasaka; Emmanuel Planel; Kentaro Tanemura; Xiaoyan Sun; Tsutomu Hashikawa; Katsuji Yoshioka; Koichi Ishiguro; Akihiko Takashima
Journal:  J Biol Chem       Date:  2002-08-20       Impact factor: 5.157

View more
  276 in total

Review 1.  Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration.

Authors:  Edward B Lee; Virginia M-Y Lee; John Q Trojanowski
Journal:  Nat Rev Neurosci       Date:  2011-11-30       Impact factor: 34.870

2.  Cell biology. A unifying role for prions in neurodegenerative diseases.

Authors:  Stanley B Prusiner
Journal:  Science       Date:  2012-06-22       Impact factor: 47.728

3.  Sensitive Detection of Proteopathic Seeding Activity with FRET Flow Cytometry.

Authors:  Jennifer L Furman; Brandon B Holmes; Marc I Diamond
Journal:  J Vis Exp       Date:  2015-12-08       Impact factor: 1.355

4.  Beyond amyloid: getting real about nonamyloid targets in Alzheimer's disease.

Authors:  Karl Herrup; Maria C Carrillo; Dale Schenk; Angela Cacace; Susan Desanti; Robert Fremeau; Ratan Bhat; Marcie Glicksman; Patrick May; Russell Swerdlow; Linda J Van Eldik; Lisa J Bain; Samantha Budd
Journal:  Alzheimers Dement       Date:  2013-07       Impact factor: 21.566

Review 5.  Prions and the potential transmissibility of protein misfolding diseases.

Authors:  Allison Kraus; Bradley R Groveman; Byron Caughey
Journal:  Annu Rev Microbiol       Date:  2013-06-28       Impact factor: 15.500

6.  Tau protein aggregates inhibit the protein-folding and vesicular trafficking arms of the cellular proteostasis network.

Authors:  Anan Yu; Susan G Fox; Annalisa Cavallini; Caroline Kerridge; Michael J O'Neill; Joanna Wolak; Suchira Bose; Richard I Morimoto
Journal:  J Biol Chem       Date:  2019-04-01       Impact factor: 5.157

7.  Multiple mechanisms of extracellular tau spreading in a non-transgenic tauopathy model.

Authors:  Meghan N Le; Wonhee Kim; Sangmook Lee; Ann C McKee; Garth F Hall
Journal:  Am J Neurodegener Dis       Date:  2012-11-25

8.  Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy.

Authors:  Monica Javidnia; Michaeline L Hebron; Yue Xin; Nikolas G Kinney; Charbel E-H Moussa
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

9.  Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like tauopathy.

Authors:  Michiyo Iba; Jing L Guo; Jennifer D McBride; Bin Zhang; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

10.  Changes in proteome solubility indicate widespread proteostatic disruption in mouse models of neurodegenerative disease.

Authors:  Michael C Pace; Guilian Xu; Susan Fromholt; John Howard; Keith Crosby; Benoit I Giasson; Jada Lewis; David R Borchelt
Journal:  Acta Neuropathol       Date:  2018-08-23       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.